Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001337394 | SCV001530997 | uncertain significance | Glycogen storage disease, type II | 2020-12-29 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine with proline at codon 369 of the GAA protein (p.Leu369Pro). The leucine residue is highly conserved and there is a moderate physicochemical difference between leucine and proline. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant has been reported to affect GAA protein function (PMID: 23430493). This variant has been observed in individual(s) with Pompe disease (PMID: 23430493). This variant is not present in population databases (ExAC no frequency). |
Mendelics | RCV001337394 | SCV002516424 | pathogenic | Glycogen storage disease, type II | 2022-05-04 | criteria provided, single submitter | clinical testing |